Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies

BACKGROUND: While radiation and chemotherapy are primarily purposed for their cytotoxic effects, a growing body of preclinical and clinical evidence demonstrates an immunogenic potential for these standard therapies. Accordingly, we sought to characterize the immunogenic potential of radiation and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowalczyk, Joshua T, Fabian, Kellsye P, Padget, Michelle R, Lopez, Diana C, Hoke, Austin TK, Allen, Clint T, Hermsen, Mario, London,, Nyall R, Hodge, James W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791467/
https://www.ncbi.nlm.nih.gov/pubmed/36564129
http://dx.doi.org/10.1136/jitc-2022-005752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791467/
https://www.ncbi.nlm.nih.gov/pubmed/36564129
http://dx.doi.org/10.1136/jitc-2022-005752

Ejemplares similares